EVE Historical Income Statement

Stocks . Australia . 
Stock . EVE Health Group
EVE Stock   0  0.00  0.00%   
Historical analysis of EVE Health income statement accounts such as Selling General Administrative of 625.9 K or Other Operating Expenses of 2.8 M can show how well EVE Health Group performed in making a profits. Evaluating EVE Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of EVE Health's future profits or losses.
Cash Flow   Balance Sheet     Income Statement
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining EVE Health Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether EVE Health Group is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EVE Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About EVE Income Statement Analysis

EVE Health Group Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to EVE Health shareholders. The income statement also shows EVE investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Balance Sheet
Statement
Details
Cash Flow
Statement
Details

EVE Health Income Statement Chart

At this time, EVE Health's Interest Expense is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 2.4 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 2.8 M in 2024.
Selling General Administrative  Total Operating Expenses  Selling And Marketing Expenses  
Add Fundamental

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from EVE Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into EVE Health Group current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EVE Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, EVE Health's Interest Expense is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 2.4 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 2.8 M in 2024.

EVE Health income statement Correlations

Depreciation And Amortization
Interest Expense
Selling General Administrative
Other Operating Expenses
Operating Income
Ebit
Ebitda
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income
Income Tax Expense
Total Revenue
Gross Profit
Discontinued Operations
Selling And Marketing Expenses
Net Income From Continuing Ops
Cost Of Revenue
Interest Income
Extraordinary Items
Net Interest Income
Reconciled Depreciation
Depreciation And Amortization
-0.1-0.070.13-0.21-0.12-0.030.030.10.110.11-0.13-0.04-0.160.340.23-0.230.00.150.27-0.020.18
Interest Expense
-0.1-0.170.64-0.46-0.22-0.230.180.20.230.16-0.170.680.070.420.2-0.50.60.370.53-0.02-0.09
Selling General Administrative
-0.07-0.17-0.20.070.040.040.0-0.02-0.070.01-0.04-0.20.56-0.04-0.050.31-0.34-0.130.040.24-0.51
Other Operating Expenses
0.130.64-0.2-0.93-0.35-0.340.250.130.260.07-0.20.95-0.450.610.68-0.870.960.190.65-0.380.46
Operating Income
-0.21-0.460.07-0.930.350.33-0.21-0.07-0.21-0.020.2-0.790.57-0.59-0.70.88-0.87-0.15-0.580.5-0.59
Ebit
-0.12-0.220.04-0.350.351.0-0.55-0.68-0.91-0.670.92-0.320.18-0.35-0.350.38-0.34-0.11-0.340.2-0.18
Ebitda
-0.03-0.230.04-0.340.331.0-0.55-0.68-0.91-0.660.91-0.330.17-0.32-0.330.37-0.34-0.1-0.320.2-0.16
Total Operating Expenses
0.030.180.00.25-0.21-0.55-0.55-0.160.23-0.17-0.230.23-0.080.00.16-0.20.24-0.030.03-0.120.1
Income Before Tax
0.10.2-0.020.13-0.07-0.68-0.68-0.160.910.99-0.890.190.110.410.19-0.150.140.20.440.09-0.11
Total Other Income Expense Net
0.110.23-0.070.26-0.21-0.91-0.910.230.910.9-0.970.3-0.040.440.31-0.310.290.190.46-0.050.05
Net Income
0.110.160.010.07-0.02-0.67-0.66-0.170.990.9-0.890.120.140.380.12-0.10.070.230.390.11-0.12
Income Tax Expense
-0.13-0.17-0.04-0.20.20.920.91-0.23-0.89-0.97-0.89-0.190.01-0.35-0.190.23-0.18-0.21-0.340.04-0.03
Total Revenue
-0.040.68-0.20.95-0.79-0.32-0.330.230.190.30.12-0.19-0.270.550.64-0.750.960.160.66-0.230.28
Gross Profit
-0.160.070.56-0.450.570.180.17-0.080.11-0.040.140.01-0.27-0.24-0.340.59-0.49-0.1-0.030.53-0.97
Discontinued Operations
0.340.42-0.040.61-0.59-0.35-0.320.00.410.440.38-0.350.55-0.240.6-0.720.560.520.95-0.220.26
Selling And Marketing Expenses
0.230.2-0.050.68-0.7-0.35-0.330.160.190.310.12-0.190.64-0.340.6-0.810.68-0.240.67-0.640.3
Net Income From Continuing Ops
-0.23-0.50.31-0.870.880.380.37-0.2-0.15-0.31-0.10.23-0.750.59-0.72-0.81-0.85-0.2-0.680.69-0.58
Cost Of Revenue
0.00.6-0.340.96-0.87-0.34-0.340.240.140.290.07-0.180.96-0.490.560.68-0.850.150.62-0.370.5
Interest Income
0.150.37-0.130.19-0.15-0.11-0.1-0.030.20.190.23-0.210.16-0.10.52-0.24-0.20.150.40.160.14
Extraordinary Items
0.270.530.040.65-0.58-0.34-0.320.030.440.460.39-0.340.66-0.030.950.67-0.680.620.4-0.160.03
Net Interest Income
-0.02-0.020.24-0.380.50.20.2-0.120.09-0.050.110.04-0.230.53-0.22-0.640.69-0.370.16-0.16-0.47
Reconciled Depreciation
0.18-0.09-0.510.46-0.59-0.18-0.160.1-0.110.05-0.12-0.030.28-0.970.260.3-0.580.50.140.03-0.47
Click cells to compare fundamentals

EVE Health Account Relationship Matchups

High Positive Relationship

Ebitda
+ 1.0
Ebit
Net Income
+ 0.99
Income Before Tax
Cost Of Revenue
+ 0.96
Other Operating Expenses
Cost Of Revenue
+ 0.96
Total Revenue
Total Revenue
+ 0.95
Other Operating Expenses
Extraordinary Items
+ 0.95
Discontinued Operations

High Negative Relationship

Reconciled Depreciation
- 0.97
Gross Profit
Income Tax Expense
- 0.97
Total Other Income Expense Net
Operating Income
- 0.93
Other Operating Expenses
Total Other Income Expense Net
- 0.91
Ebitda
Total Other Income Expense Net
- 0.91
Ebit
Income Tax Expense
- 0.89
Net Income

EVE Health income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization277.8K324.5K226.3K166.9K7.0K6.7K
Interest Expense7.3K48.3K22.0K34.9K40.2K42.2K
Selling General Administrative281.4K327.2K163.1K135.5K992.8K625.9K
Other Operating Expenses5.1M6.6M5.9M4.6M3.7M2.8M
Operating Income(2.7M)(3.8M)(3.9M)(2.3M)(1.5M)(1.6M)
Ebit(2.7M)(3.8M)(4.8M)(2.3M)(1.5M)(1.6M)
Ebitda(2.5M)(3.5M)(4.5M)(2.2M)(1.5M)(1.6M)
Total Operating Expenses2.3M3.1M2.9M1.9M2.4M2.4M
Income Before Tax(2.3M)(3.2M)(4.8M)(2.1M)(1.5M)(1.6M)
Total Other Income Expense Net396.4K629.2K(457.4K)249.1K(5.2K)(5.4K)
Net Income(2.4M)(3.6M)(5.4M)(4.0M)(1.9M)(2.0M)
Income Tax Expense(604.0K)468.4K594.6K1.9M352.3K334.7K
Total Revenue2.3M2.8M2.0M2.3M2.1M1.4M
Net Income Applicable To Common Shares(2.4M)(3.6M)(5.4M)(1.6M)(1.5M)(1.4M)
Gross Profit(451.9K)(713.5K)(1.0M)(336.9K)877.0K920.8K
Selling And Marketing Expenses670.1K1.2M2.0M1.3M1.1M911.4K
Net Income From Continuing Ops(2.4M)(3.6M)(5.4M)(2.3M)(1.5M)(1.6M)
Cost Of Revenue2.8M3.5M3.0M2.7M1.3M1.5M
Interest Income658.8K26.3K7.2K24.8K22.4K21.2K
Net Interest Income(7.3K)(22.0K)(4.0M)118.0(34.9K)(36.7K)
Reconciled Depreciation277.8K324.5K325.7K166.9K7.0K6.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for EVE Stock Analysis

When running EVE Health's price analysis, check to measure EVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVE Health is operating at the current time. Most of EVE Health's value examination focuses on studying past and present price action to predict the probability of EVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EVE Health's price. Additionally, you may evaluate how the addition of EVE Health to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY